Cite
HARVARD Citation
Mercurio, L. et al. (2016). Targeting CXCR4 by a selective peptide antagonist modulates tumor microenvironment and microglia reactivity in a human glioblastoma model. Journal of experimental & clinical cancer research. 35 (1), pp. 1-15. [Online].